Research and resources
A library that puts peer-reviewed research and the essays of women living this next to each other. Filter by phase, region or kind to find what's actually for you.
Filters
Talk to your doctor or specialist before changing treatment. Each article carries an Evidence A / B / C tag.
How to read this page →Evidence A / B / C
Strong: major guidelines, large randomized trials, or systematic reviews. Safe to act on.
Moderate: a solid trial or consistent observational studies. Worth considering, with nuance.
Early or limited: small studies, mixed results, or expert opinion. Useful context, not a basis for big calls.
Region tags
International bodies (WHO, IMS, Cochrane) or guidance that applies regardless of where you live.
Country-specific guidelines, regulators, or clinical bodies (e.g. SOGC, NAMS, NICE).
Lived experience and essays. Not pinned to a country, these stories travel.
Filtering by region keeps personal stories visible so you don't lose voices when you narrow the clinical view.
Have a study or essay you think belongs here? Send it our way and a moderator will review it for the library.
Free for everyone, read smarter, not more
The internet has more menopause content than you can read in a lifetime. These three filters keep the noise out.
A randomized trial in The Lancet and a TikTok of someone's gut-feel are both 'studies' on Google. Knowing which is which is half the battle.
Try this week: Before you trust a claim, find the original. Look for: peer review, sample size, year, who funded it. If it's a single Instagram graphic with no link, close the tab.
Beyond Nila
The professional documents and journal pieces clinicians cite. Useful when you want to read the actual source behind the guidance.
by The Menopause Society (NAMS)
The current professional consensus document. Dense, but it's the thing your doctor's guidelines are based on.
by Crandall et al., Menopause (NAMS), 2017
The reference clinicians cite when discussing local vaginal estrogen for GSM after breast cancer. Cross-link from /treatments/cancer-risk.
by de Jong et al., 2023
One of the first peer-reviewed pieces naming the pattern clinicians are now seeing in clinic.
by World Economic Forum, Kearney Health Institute, Gates Foundation, Wellcome Leap
Maps where women's health innovation is actually happening across funding, evidence and product pipelines. Names menopause as under-resourced relative to disease burden.
No affiliate links. No paid placement. We update this shelf roughly every quarter.
